<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04796493</url>
  </required_header>
  <id_info>
    <org_study_id>H-20058773</org_study_id>
    <nct_id>NCT04796493</nct_id>
  </id_info>
  <brief_title>Objective Grading of MTS With LSCI and Thermography</brief_title>
  <acronym>MTS LSCI</acronym>
  <official_title>Is Objective Grading of Mesenteric Traction Syndrome With Laser Speckle Contrast Imaging Interchangeable With Digital Thermography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mesenteric traction syndrome (MTS) is defined as hypotension, tachycardia and facial flushing&#xD;
      in the first hour of surgery, caused by mesenteric traction/abdominal exploration. MTS occurs&#xD;
      frequently during abdominal surgery, with incidence around 80 % during open surgery, and&#xD;
      lower during minimally invasive surgery. MTS can be divided into different severities using&#xD;
      the degree of facial flushing, with the most severe level of MTS being associated with&#xD;
      increased postoperative morbidity.&#xD;
&#xD;
      Today MTS i diagnosed and graded subjectively by the surgical team, with marked difficulty&#xD;
      and limitations. Therefore the investigators developed a cut-off value using the Laser&#xD;
      Speckle Contrast Imaging (LSCI), which the investigators wish to confirm in a new cohort,&#xD;
      while also examining whether LSCI is interchangeable with digital thermography, which is&#xD;
      simpler and cheaper to perfom.&#xD;
&#xD;
      The investigators will measure facial perfusion during the first hour of surgery and take&#xD;
      blood samples at predefined timepoints to use for biochemical verification of the different&#xD;
      severities of MTS.&#xD;
&#xD;
      Three cohorts will be included 45 open esophagectomies or gastrectomies 50 whipple surgery 55&#xD;
      robot assisted esophagectomies or gastrectomies These patients will be use in multiple&#xD;
      articles examining different aspects of MTS&#xD;
&#xD;
      One study examining LSCI and thermography for the identification and grading of MTS will use&#xD;
      60 patients undergoing open esophagectomy or gastrectomy or whipple surgery, in this study&#xD;
      patients will not be excluded if they are found to be disseminated.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 16, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of MTS - measured facial perfusion</measure>
    <time_frame>first hour of surgery</time_frame>
    <description>Facial perfusion measured with LSCI and Digital Thermography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical markers of MTS - prostacyclin</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of postoperative impact of MTS - IL6 and endothelial damage markers</measure>
    <time_frame>During and after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day postoperative morbidity</measure>
    <time_frame>30 days post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of objective MTS during whipples procedure with methylprednisolone prophylaxis</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of objective MTS during minimally invasive surgery</measure>
    <time_frame>during surgery</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Mesenteric Traction Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        3 cohorts&#xD;
&#xD;
          -  open esophagectomies and gastrectomies&#xD;
&#xD;
          -  robotic assisted esophagectomies and gastrectomies&#xD;
&#xD;
          -  whipples procedure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Undergoing curative surgery for esopageal, gastric, doudenal or pancreatic cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known flushing disease&#xD;
&#xD;
          -  Patients recieving NSAID and corticosteroid presurgery, Whipple is allowed to recieve&#xD;
             single dose of 125 mg Methylprednisone as part of the standard of care at our&#xD;
             facility.&#xD;
&#xD;
          -  Palliative surgery&#xD;
&#xD;
          -  Surgery not completed due to disseminated disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>August Olsen, PHD student</last_name>
    <phone>+4521571240</phone>
    <phone_ext>45</phone_ext>
    <email>augustolsen2@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Achiam, Dr.med</last_name>
    <phone_ext>45</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>København Ø</city>
        <state>Hovedstaden</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>August Olsen, PhD student</last_name>
      <phone>+4521571240</phone>
      <email>augustolsen2@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2021</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>August Adelsten Olsen</investigator_full_name>
    <investigator_title>MD PhD student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

